Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “anti-”

1,068 pharma patents match "anti-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,068
Index total 30,257
Page 20 / 45

Quick answer

This filtered view shows 1,068 pharmaceutical patents matching "anti-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,068 results for “anti-” · 30,257 patents in full index Clear search

  1. US 10906864

    Nitroalkene non steroidal anti-inflammatory drugs (NA-NSAIDS) and methods of treating inflammation related conditions

    INSTITUT PASTEUR DE MONTEVIDEO · Granted Feb 2, 2021 · Expires Jan 28, 2041

    granted

  2. US 10898451

    Methods of treating anti-NMDA receptor encephalitis with tramadol

    The Board of Regents of the University of Texas System · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted

  3. US 10899826

    Pharmaceutical compositions for an anti-CGRP antagonist antibody

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted

  4. US 10899839

    Anti-Ryk antibodies and methods of using the same

    Tire Regents of the University of California · Granted Jan 26, 2021 · Expires Jan 21, 2041

    granted

  5. US 10894034

    Anti-neoplastic compounds and methods targeting QSOX1

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jan 19, 2021 · Expires Jan 14, 2041

    granted

  6. US 10881644

    Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs

    Lutonix, Inc. · Granted Jan 5, 2021 · Expires Dec 31, 2040

    granted

  7. US 10875915

    Anti-CXCR5 antibodies and compositions and uses thereof

    The Regents of the University of California · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  8. US 10875913

    Methods of treatment using activatable anti-EGFR antibodies

    CytomX Therapeutics, Inc. · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  9. US 10876116

    Anti-ARID3a treatments for inflammatory disorders

    The Board of Regents of the University of Oklahoma · Granted Dec 29, 2020 · Expires Dec 24, 2040

    granted

  10. US 10870687

    Anti-human papillomavirus 16 E7 T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  11. US 10869863

    Multi-arm polymeric targeting anti-cancer conjugate

    BrightGene Bio-Medical Technology Co., Ltd. · Granted Dec 22, 2020 · Expires Dec 17, 2040

    granted

  12. US 10864304

    Anti-infective antimicrobial-containing biomaterials

    ATRIUM MEDICAL CORPORATION · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted

  13. US 10864252

    Anti-SSX-2 T cell receptors and related materials and methods of use

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Dec 15, 2020 · Expires Dec 10, 2040

    granted

  14. US 10851173

    Anti-OX40 antibodies and methods of using the same

    The Board of Regents of the University of Texas System · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted

  15. US 10851112

    Anti-HCMV virus compound

    Medshine Discovery Inc. · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted

  16. US 10849878

    Agent exhibiting anti-stress, anxiolytic and anti-depression activity, and composition based thereon

    OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU “NORMOFARM” · Granted Dec 1, 2020 · Expires Nov 26, 2040

    granted

  17. US 10844137

    Anti-CTLA-4 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted

  18. US 10829550

    Polynucleotides encoding anti-CXCL13 antibodies

    VACCINEX, INC. · Granted Nov 10, 2020 · Expires Nov 5, 2040

    granted

  19. US 10822427

    Anti-CSPG4 fusions with interferon for the treatment of malignancy

    The Regents of the University of California · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  20. US 10822426

    Humanized anti-CD73 antibodies

    Corvus Pharmaceuticals, Inc. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  21. US 10822414

    Anti-PD-1 antibodies, compositions comprising anti-PD-1 antibodies and methods of using anti-PD-1 antibodies

    Sutro Biopharma, Inc. · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  22. US 10822588

    Agents and methods to elicit anti-tumor immune response

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 3, 2020 · Expires Oct 29, 2040

    granted

  23. US 10815301

    Anti-CD30 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  24. US 10806780

    Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.